Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-24 @ 5:37 PM
NCT ID:
NCT05426668
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent form
* Age ≥18 years
* NSCLC, non-curatively treatable stage III or stage IV with palliative treatment indication
* Immunocheckpoint-therapy for malignant disease (Immunotherapy as monotherapy, double immunotherapy or combination with chemotherapy)
Exclusion Criteria:
* Person is unable to understand the nature, importance and scope of the clinical trial
* Participation in an interventional study
* Hb value \<9g/dl
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05426668
Study Brief:
Protocol Section:
NCT05426668